GEHC logo

GEHC EBITDA

Annual EBITDA:

$3.67B+$153.00M(+4.36%)
December 31, 2024

Summary

  • As of today, GEHC annual EBITDA is $3.67 billion, with the most recent change of +$153.00 million (+4.36%) on December 31, 2024.
  • During the last 3 years, GEHC annual EBITDA has risen by +$126.00 million (+3.56%).
  • GEHC annual EBITDA is now at all-time high.

Performance

1-Year Change

+4.36%

3-Year Change

+3.56%

5-Year Change

+29.18%

15-Year Change

+29.18%

GEHC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

97.39%
GEHC annual EBITDA is higher than 97.39% of companies in Healthcare sector

Range

All-Time High

$3.67B
GEHC annual EBITDA is currently at an all-time high

3-Year Low

$3.23B
GEHC annual EBITDA is currently +13.46% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
GEHC previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 12, 2026
GEHC next annual earnings announcement is scheduled for Feb 12, 2026

OtherGEHCincome statement metrics

Annual Revenue

$19.67B
GEHC annual revenue is $19.67 billion

Annual Net Income

$2.05B
GEHC annual net profit is $2.05 billion

Annual EBIT

$3.09B
GEHC annual earnings before interest & taxes is $3.09 billion

Annual EPS

$4.34
GEHC annual earnings per share is $4.34

Quarterly EBITDA:

$846.00M+$72.00M(+9.30%)
September 30, 2025

Summary

  • As of today, GEHC quarterly EBITDA is $846.00 million, with the most recent change of +$72.00 million (+9.30%) on September 30, 2025.
  • Over the past year, GEHC quarterly EBITDA has dropped by -$5.00 million (-0.59%).
  • GEHC quarterly EBITDA is now -18.97% below its all-time high of $1.04 billion, reached on December 31, 2024.

Performance

3-Month Change

+9.3%

1-Year Change

-0.59%

3-Year Change

+0.71%

5-Year Change

-3.97%

GEHC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.4%
GEHC quarterly EBITDA is higher than 96.4% of companies in Healthcare sector

Range

All-Time High

$1.04B
GEHC quarterly EBITDA is currently -18.97% below its historical high of $1.04 billion

3-Year Low

$671.00M
GEHC quarterly EBITDA is currently +26.08% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
GEHC previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 12, 2026
GEHC next earnings announcement is scheduled for Feb 12, 2026

OtherGEHCincome statement metrics

Quarterly Revenue

$5.14B
GEHC quarterly revenue is $5.14 billion

Quarterly Net Income

$464.00M
GEHC quarterly net profit is $464.00 million

Quarterly EBIT

$697.00M
GEHC quarterly earnings before interest & taxes is $697.00 million

Quarterly EPS

$0.98
GEHC quarterly earnings per share is $0.98

TTM EBITDA:

$3.47B-$5.00M(-0.14%)
September 30, 2025

Summary

  • As of today, GEHC TTM EBITDA is $3.47 billion, with the most recent change of -$5.00 million (-0.14%) on September 30, 2025.
  • Over the past year, GEHC TTM EBITDA has increased by +$37.00 million (+1.08%).
  • GEHC TTM EBITDA is now -1.28% below its all-time high of $3.51 billion, reached on March 31, 2025.

Performance

3-Month Change

-0.14%

1-Year Change

+1.08%

3-Year Change

+6.61%

5-Year Change

+293.76%

GEHC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.76%
GEHC TTM EBITDA is higher than 96.76% of companies in Healthcare sector

Range

All-Time High

$3.51B
GEHC TTM EBITDA is currently -1.28% below its historical high of $3.51 billion

3-Year Low

$3.06B
GEHC TTM EBITDA is currently +13.51% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
GEHC previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 12, 2026
GEHC next earnings announcement is scheduled for Feb 12, 2026

OtherGEHCincome statement metrics

TTM Revenue

$20.25B
GEHC TTM revenue is $20.25 billion

TTM Net Income

$2.29B
GEHC TTM net profit is $2.29 billion

TTM EBIT

$2.90B
GEHC TTM earnings before interest & taxes is $2.90 billion

TTM EPS

$4.84
GEHC TTM earnings per share is $4.84

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$3.67B
GEHC annual EBITDA is $3.67 billion

Annual Net Income

$2.05B
GEHC annual net profit is $2.05 billion

Annual Interest Expense

$505.00M
GEHC annual interest expense is $505.00 million

Annual Income Tax

$531.00M
GEHC annual income tax is $531.00 million

Annual D&A

$580.00M
GEHC annual D&A is $580.00 million

GEHC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+4.4%-0.6%+1.1%
3Y3 Years+3.6%+0.7%+6.6%
5Y5 Years+29.2%-4.0%+293.8%

GEHC EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+13.5%-19.0%+26.1%-1.3%+13.5%
5Y5-Yearat high+13.5%-19.0%+26.3%-1.3%+293.8%
All-TimeAll-Timeat high+29.2%-19.0%+26.3%-1.3%+293.8%

GEHC EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$846.00M(+9.3%)
$3.47B(-0.1%)
Jun 2025
-
$774.00M(-3.9%)
$3.47B(-1.1%)
Mar 2025
-
$805.00M(-22.9%)
$3.51B(+1.4%)
Dec 2024
$3.67B(+4.4%)
$1.04B(+22.7%)
$3.47B(+1.0%)
Sep 2024
-
$851.00M(+4.5%)
$3.43B(+3.9%)
Jun 2024
-
$814.00M(+7.4%)
$3.30B(+2.6%)
Mar 2024
-
$758.00M(-24.9%)
$3.22B(+2.8%)
Dec 2023
$3.51B
$1.01B(+39.8%)
$3.13B(+2.5%)
Sep 2023
-
$722.00M(-1.0%)
$3.06B(-3.7%)
DateAnnualQuarterlyTTM
Jun 2023
-
$729.00M(+8.6%)
$3.17B(-4.1%)
Mar 2023
-
$671.00M(-28.2%)
$3.31B(+0.0%)
Dec 2022
$3.23B(-8.7%)
$934.00M(+11.2%)
$3.31B(+1.6%)
Sep 2022
-
$840.00M(-2.7%)
$3.25B(+34.8%)
Jun 2022
-
$863.00M(+28.8%)
$2.41B(+55.6%)
Mar 2022
-
$670.00M(-24.0%)
$1.55B(+76.0%)
Dec 2021
$3.54B(+3.9%)
-
-
Dec 2021
-
$881.00M
$881.00M
Dec 2020
$3.41B(+20.0%)
-
-
Dec 2019
$2.84B
-
-

FAQ

  • What is GE HealthCare Technologies Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for GE HealthCare Technologies Inc.?
  • What is GE HealthCare Technologies Inc. annual EBITDA year-on-year change?
  • What is GE HealthCare Technologies Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for GE HealthCare Technologies Inc.?
  • What is GE HealthCare Technologies Inc. quarterly EBITDA year-on-year change?
  • What is GE HealthCare Technologies Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for GE HealthCare Technologies Inc.?
  • What is GE HealthCare Technologies Inc. TTM EBITDA year-on-year change?

What is GE HealthCare Technologies Inc. annual EBITDA?

The current annual EBITDA of GEHC is $3.67B

What is the all-time high annual EBITDA for GE HealthCare Technologies Inc.?

GE HealthCare Technologies Inc. all-time high annual EBITDA is $3.67B

What is GE HealthCare Technologies Inc. annual EBITDA year-on-year change?

Over the past year, GEHC annual EBITDA has changed by +$153.00M (+4.36%)

What is GE HealthCare Technologies Inc. quarterly EBITDA?

The current quarterly EBITDA of GEHC is $846.00M

What is the all-time high quarterly EBITDA for GE HealthCare Technologies Inc.?

GE HealthCare Technologies Inc. all-time high quarterly EBITDA is $1.04B

What is GE HealthCare Technologies Inc. quarterly EBITDA year-on-year change?

Over the past year, GEHC quarterly EBITDA has changed by -$5.00M (-0.59%)

What is GE HealthCare Technologies Inc. TTM EBITDA?

The current TTM EBITDA of GEHC is $3.47B

What is the all-time high TTM EBITDA for GE HealthCare Technologies Inc.?

GE HealthCare Technologies Inc. all-time high TTM EBITDA is $3.51B

What is GE HealthCare Technologies Inc. TTM EBITDA year-on-year change?

Over the past year, GEHC TTM EBITDA has changed by +$37.00M (+1.08%)
On this page